Eyebright Medical Technology (Beijing) Balance Sheet Health
Financial Health criteria checks 5/6
Eyebright Medical Technology (Beijing) has a total shareholder equity of CN¥2.5B and total debt of CN¥614.8M, which brings its debt-to-equity ratio to 24.2%. Its total assets and total liabilities are CN¥3.4B and CN¥863.1M respectively. Eyebright Medical Technology (Beijing)'s EBIT is CN¥412.0M making its interest coverage ratio 34.3. It has cash and short-term investments of CN¥469.3M.
Key information
24.2%
Debt to equity ratio
CN¥614.83m
Debt
Interest coverage ratio | 34.3x |
Cash | CN¥469.25m |
Equity | CN¥2.54b |
Total liabilities | CN¥863.14m |
Total assets | CN¥3.41b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 688050's short term assets (CN¥1.2B) exceed its short term liabilities (CN¥247.5M).
Long Term Liabilities: 688050's short term assets (CN¥1.2B) exceed its long term liabilities (CN¥615.6M).
Debt to Equity History and Analysis
Debt Level: 688050's net debt to equity ratio (5.7%) is considered satisfactory.
Reducing Debt: 688050's debt to equity ratio has increased from 0.1% to 24.2% over the past 5 years.
Debt Coverage: 688050's debt is well covered by operating cash flow (48.6%).
Interest Coverage: 688050's interest payments on its debt are well covered by EBIT (34.3x coverage).